Refine
Has Fulltext
- yes (26) (remove)
Is part of the Bibliography
- yes (26)
Year of publication
Document Type
- Journal article (26)
Language
- English (26)
Keywords
- colorectal cancer (5)
- CRC (2)
- Germany (2)
- MIZ1 (2)
- MYC (2)
- Rectal cancer (2)
- cancer (2)
- chemotherapy (2)
- complication (2)
- therapy (2)
- 5-fluorouracil (1)
- BM (1)
- CCR7 (1)
- COVID-19 pandemic (1)
- CX5461 (1)
- Chirurgie (1)
- Cushing (1)
- FWGE (1)
- HUWE1 (1)
- Improved survival (1)
- LAMN (1)
- Laparoscopy (1)
- Lymph nodes (1)
- MAPK signaling cascades (1)
- MTL30 (1)
- Minimally invasive surgery (1)
- Oncology (1)
- RNAPOL1 (1)
- Radiochemotherapy (1)
- SSI (1)
- Surgery (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- TME (1)
- Time interval (1)
- ZfKD (1)
- abdominal surgery (1)
- acute appendicitis (1)
- adjuvant (1)
- adrenal surgery (1)
- adrenal tumors (1)
- adrenalectomia (1)
- adrenocortical adenocarcinoma (1)
- adrenocortical carcinoma (1)
- antibiotics (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- autophagy (1)
- benzoquinone (1)
- bladder (1)
- brain metastases (1)
- caco-2 cells (1)
- cancer cells (1)
- cancer diagnosis (1)
- capture (1)
- carcinomas (1)
- catheterization (1)
- catheters (1)
- cerebral metastases (1)
- chemokine receptor (1)
- colon (1)
- colon cancer (1)
- colon resection (1)
- colorectal carcinoma (1)
- complications (1)
- conventional laparoscopic appendectomy (1)
- cost-effectiveness (1)
- cytostatic (1)
- cytotoxicity (1)
- definition (1)
- digestive system (1)
- discharge definition (1)
- drug discovery (1)
- epidemiology (1)
- epidural block (1)
- gastric cancer (1)
- geriatric (1)
- laparoscopic appendectomy (1)
- laparoscopic right colectomy (1)
- left hemicolectomy (1)
- low-grade mucinous neoplasm (1)
- lymph nodes (1)
- meta-analysis (1)
- metastasis (1)
- mortality (1)
- multimodal (1)
- neoadjuvant (1)
- neuroblastoma – diagnosis (1)
- octogenerians (1)
- open appendectomy (1)
- organoid (1)
- outcome (1)
- oxaliplatin (1)
- pancreatectomy (1)
- patient-derived organoid (PDOs) (1)
- patient-derived tumor organoid (PDTO) (1)
- pediatric (1)
- pediatric adrenocortical adenoma (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical tumor (1)
- pharmacology (1)
- postoperative inflammation (1)
- prognostic factors (1)
- protein expression (1)
- protein synthesis (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- reactive oxygen species (1)
- rectum (1)
- ribosome (1)
- risk factor (1)
- robotic surgery (1)
- single-port appendectomy (1)
- small interferring RNA (1)
- superior (1)
- surgery (1)
- surgical and invasive medical procedures (1)
- surgical care (1)
- surgical site infection (1)
- survival (1)
- systematic review (1)
- translation initiation (1)
- tumor disease (1)
- ubiquitination (1)
- urinary tract infections (1)
- volume (1)
- wound infection (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (26) (remove)
Background
The management of rectal cancer (RC) has substantially changed over the last decades with the implementation of neoadjuvant chemoradiotherapy, adjuvant therapy and improved surgery such as total mesorectal excision (TME). It remains unclear in which way these approaches overall influenced the rate of local recurrence and overall survival.
Methods
Clinical, histological and survival data of 658 out of 662 consecutive patients with RC were analyzed for treatment and prognostic factors from a prospectively expanded single-institutional database. Findings were then stratified according to time of diagnosis in patient groups treated between 1993 and 2001 and 2002 and 2010.
Results
The study population included 658 consecutive patients with rectal cancer between 1993 and 2010. Follow up data was available for 99.6% of all 662 treated patients. During the time period between 2002 and 2010 significantly more patients underwent neoadjuvant chemoradiotherapy (17.6% vs. 60%) and adjuvant chemotherapy (37.9% vs. 58.4%). Also, the rate of reported TME during surgery increased. The rate of local or distant metastasis decreased over time, and tumor related 5-year survival increased significantly with from 60% to 79%.
Conclusion
In our study population, the implementation of treatment changes over the last decade improved the patient’s outcome significantly. Improvements were most evident for UICC stage III rectal cancer.